MEDICAL DEVICE & HEALTHCARE VENTURE CAPITAL INFORMATION & STATS
Healthcare funding is critical to the advancements in the medical device, pharmaceutical, life sciences, and biotechnology areas. A large percentage of venture capital and private equity firms in the United States and abroad back these companies represent themselves as either seed, early, or late stage venture capital firms.
Medical device venture capital firms are expected to steadily increase investments in product innovations as this has turned into a multibillion-dollar, although highly-regulated, global market with continuous growth in demands and jobs. The changes and innovations in this area go hand-in-hand with the changes in healthcare, drug delivery, and pharmaceuticals.
Healthcare venture capital firms typically provide investments ranging from $100,000 to $20 million depending on the stage of development. Entrepreneurs can get access to medical device private equity, which is prominent in most regions of the United States.
Investors tend to focus on healthcare advancements that include information security solution, diagnostics, and medical technology. Reach accredited healthcare private equity and medical device funding providers and get funded through FindVenture.com.
Featured Investors
CapitalSouth Partners is a private equity firm specializing in investments in mature and lower middle market companies. The firm focuses on growth financing, management buyouts, leveraged buyouts, add-on acquisitions, recapitalizations, expansion capital, and mezzanine capital. CapitalSouth typically invests between $5 million and $25 million in each company and can arrange investments of up to $40 million through syndication. With its variety of locations and range of investments, CapitalSouth Partners represents one of the top venture capital firms in the United States, namely in the Southeast.
Salix Ventures currently has $180 million in committed capital spanning two funds. The company focuses on healthcare businesses in the service and technology space nationwide. Salix Ventures provides early and late stage backing ranging from $5 million to $7 million per portfolio company.
TA Associates Inc. is a global private equity firm backing businesses in diverse industries, including healthcare services and healthcare technology, through late stage financing, IPOs, debt financing, and M&A activity.  The company has $16 billion in capital under management and has invested in more than 400 companies since 1968.
MedVenture Associates focuses on medical technologies and provides early stage funding.  Based in California, the company was formed in 1986 and has since then set the stage for IPOs for more than 24 of its portfolio companies. Portfolio companies include Insulet, Spinal Dynamics, and Glycomed, Inc.
Pacific Venture Group is a healthcare venture capital firm with two active funds made up of limited partners. The company provides early stage and expansion funding in diverse healthcare segments.
KBL Healthcare Ventures provides early stage funding and growth equity to companies in life sciences, medical devices, healthcare services, and medical information technology. The company tends to focus on businesses with proprietary technology or innovative solutions that address market gaps. KBL Healthcare Ventures is based in New York.
Pacific Horizon Ventures is a healthcare venture capital firm focusing on early stage life sciences firms in under-penetrated markets. The company is based in Seattle, WA and has invested in businesses including SleepMed, Inc., Koronis Pharmaceutical, Inc., iScience Interventional.
Forward Ventures is a life sciences and medical device investment company and represents one of the premiere west coast venture capital firms out there today. Based in California, they are searching for business dedicated to creating and commercializing treatments for diseases. Since its inception in 1993, Forward Ventures has invested in more than 50 companies and has $500 million in funds under management.
Domain Associates Llc has been providing private/public equity to life sciences companies, including pharmaceuticals, specialty pharmaceuticals, and medical devices, since 1985. With a total of $2.5 billion in funds under management, Domain Associates supports companies from early to public status alike in financing needs.
Abingworth Management Limited is an international investment company focused in life sciences and healthcare in the US and Europe. It currently has $1.25 billion in funders under management and supports companies in all stages including venture capital, growth financing, and public markets with average total investments ranging from $20 million to $80 million.
Accel Partners is a venture capital firm with offices in Palo Alto, CA, London, China, and India. Focused on emerging industries and products, Accel Partners invests in early-stage pioneering businesses with breakthrough and technology-based innovations in diverse categories such as mobile, software, network, biotechnology, and energy.
